Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Natalizumab may reduce cognitive changes and brain atrophy rate in relapsing-remitting multiple sclerosis: a prospective, non-randomized pilot study.
Copaxone
Episode 3 with Drs. Daren Austin and Susan Van Meter on the MIRROR trial of ofatumumab
Sex differences in comorbidity at diagnosis of multiple sclerosis: A population-based study.
Rituximab (marketed as Rituxan), Information
8th International Congress on Autoimmunity
Epigenetic modifications of Dexras 1 along the nNOS pathway in an animal model of multiple sclerosis.
Remote Physical Activity Monitoring in Neurological Disease: A Systematic Review.
Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis.
Product Portfolio, Meda
Persistency of neutralizing antibodies depends on titer and interferon-beta preparation.
Neuroimmunology: Clostridium-reactive T cells are implicated in the pathogenesis of neuromyelitis optica.
UCSF Seminar: "Neuron-glia interactions regulate CNS node of Ranvier assembly."
Multiple sclerosis: association with HL-A3.
Tumor necrosis factor-α impairs oligodendroglial differentiation through a mitochondria-dependent process.
Long-term effectiveness of glatiramer acetate in clinical practice conditions.
Reversible cerebral vasoconstriction syndrome associated with interferon beta-1a use for multiple sclerosis.
National MS Society: Ralph I. Straus Award
Interferon-beta is a potent promoter of nerve growth factor production by astrocytes.
Multiple Sclerosis.
Mylan's ANDA for Three Times Per Week Generic Copaxone® 40 mg/mL Accepted for Filing by FDA
Biogen Idec and AbbVie announce positive top-line results from Phase 3 study investigating daclizumab high-yield process in multiple sclerosis
Multiple sclerosis: Mitoxantrone promotes differential effects on immunocompetent cells in vitro.
Chronic Inflammatory Demyelinating Polyneuropathy Following Anti-TNF-α Therapy With Infliximab for Crohn's Disease.
Allelic combinations of immune-response genes associated with glatiramer acetate treatment response in Russian multiple sclerosis patients.

Pages